Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 22, 2019 01:00 ET | Source: Kiadis Pharma N.V.

Kiadis Pharma announces formation of renowned Scientific Advisory Board

Amsterdam, The Netherlands, 22 October 2019 – Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company, today announces...
October 17, 2019 11:50 ET | Source: Kiadis Pharma N.V.

Kiadis Pharma provides regulatory update on ATIR101

Kiadis no longer expects EU conditional marketing authorization for ATIR101 in 2020Kiadis plans to refile at the conclusion of the ongoing phase 3 trial Amsterdam, The Netherlands, 17 October 2019 –...
September 10, 2019 01:00 ET | Source: Kiadis Pharma N.V.

Kiadis Pharma announces results for the six months ended June 30, 2019

Kiadis to hold conference call with investors today at 15:00 CEST Amsterdam, The Netherlands, September 10, 2019 – Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and...
August 19, 2019 11:45 ET | Source: Kiadis Pharma N.V.

Kiadis Pharma Announces Investor Events for September 2019

Company announces Notice of Results for the six months ended June 30, 2019 Amsterdam, The Netherlands, August 19, 2019 – Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam...
July 31, 2019 11:45 ET | Source: Kiadis Pharma N.V.

Kiadis Pharma to present at upcoming conference in August 2019

Kiadis Pharma to present at upcoming conference in August 2019 Amsterdam, The Netherlands, July 31, 2019 – Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and Brussels:...
June 24, 2019 11:50 ET | Source: Kiadis Pharma Netherlands B.V.

Kiadis Pharma Announces Results Annual General Meeting

Kiadis Pharma Announces Results Annual General Meeting Amsterdam, The Netherlands, June 24, 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels:...
June 06, 2019 01:30 ET | Source: Kiadis Pharma Netherlands B.V.

Kiadis Pharma completes acquisition of CytoSen Therapeutics, Inc.

Amsterdam, The Netherlands, June 6, 2019 - Kiadis Pharma N.V. ("Kiadis" or the "Company") (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company, today announces that it...
June 03, 2019 11:45 ET | Source: Kiadis Pharma Netherlands B.V.

Kiadis Pharma to present at upcoming conferences in June 2019

Kiadis Pharma to present at upcoming conferences in June 2019 Amsterdam, The Netherlands, June 3, 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or...
May 31, 2019 02:00 ET | Source: Kiadis Pharma Netherlands B.V.

Kiadis Pharma raises c.EUR 28 million in a private placement of c.3.7 million new shares

Not for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, Japan, south africa or Any other jurisdiction in which such release,...
May 30, 2019 11:45 ET | Source: Kiadis Pharma Netherlands B.V.

Kiadis Pharma launches a private placement of new shares to raise approximately EUR 25 million

Not for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, Japan, south africa or Any other jurisdiction in which such release,...